http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2604073-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3675d00f905863ab0ddd24d2bb60daf5 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-722 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
filingDate | 1994-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b25560a0dba5e380288b7ebeb52a92d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0edb82a35697b7821510ea110e56312e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a42c90cd43f0a2a602be23d5ba4d7fe8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faf28c183f32d5374c14748f740ec4fe |
publicationDate | 1995-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2604073-A1 |
titleOfInvention | Poly-.beta.-1.fwdarw.4-n-acetylglucosamine |
abstract | A method of producing and purifying poly-.beta.-1.fwdarw.4-N-acetylflucosamine(p-GlcNAc)polysaccharide species and their derivatives is described. The polysaccharides produced by this method are free of proteins, and substantially free of single amino acids, and other organic and inorganic contaminants. These p-GlcNAc polysaccharides may be used commercially by the biomedical, pharmaceutical, and cosmetic industries in slow drug delivery systems, cell encapsulation systems, and treatments for the prevention of post-surgical adhesions. The figure shows the chemical structure of 100 % p-GlcNAc, wherein "n" is an integer from about 4,000 to about 150,000. |
priorityDate | 1993-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467890502 |
Total number of triples: 16.